Clariant Sells Healthcare Packaging to Arsenal Capital

Clariant Sells Healthcare Packaging to Arsenal Capital
Clariant Sells Healthcare Packaging to Arsenal Capital

Swiss specialty chemicals company Clariant has agreed to sell its healthcare packaging business to a newly formed affiliate of US private equity group Arsenal Capital Partners for 308 million Swiss francs.

The business supplies packaging to protect pharmaceutical products from moisture and oxygen, including drop-in items such as canisters and packets, integrated desiccant systems and specially designed plastic bottles containing oxygen barrier materials. It has manufacturing facilities in France, China, India and the US, employs around 600 staff and generated sales of about 135 million Swiss francs in 2018.

Clariant has not given a reason for the divestment, which is expected to close in the fourth quarter of 2019.

New-York based Arsenal describes itself as a “specialized” investor with a focus on activities in the specialty industrials and healthcare sectors because of their “attractive growth trends, large number of technology and innovation-rich companies, and opportunities to create value-added solutions.”

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.